过去一年中添加的文章,按日期排序
1260 DAV132 colon-targeted adsorbent prevents antibiotic-related dysbiosis in human volunteers and fecal microbiota transplantation mitigates anti-PD-1 resistance …
…, R Boidot, C Le Bescop, T Loppinet, T Corbel… - 2024 - jitc.bmj.com
11 天前 - … Tumor infiltrating lymphocytes were analyzed by flow … a CD8 T cell dependent
mechanism. These results provide rationale to launch clinical trials combining DAV132 in cancer …
mechanism. These results provide rationale to launch clinical trials combining DAV132 in cancer …
[HTML][HTML] 940 SOT201, a novel cis-acting PD-1/IL-15 mutein-based immunocytokine that reinvigorates anti-tumor immunity qualitatively superior to PD-1/IL-2v-based IL …
H Matuskova, P Marasek, V Mazhara, E Simonova… - 2024 - jitc.bmj.com
11 天前 - … of PD-1 + CD8 + tumor infiltrating lymphocytes (TILs) via cis … -specific CD8 + T cells
and stimulated higher expansion … + T cells concomitantly limiting the peripheral CD8 + T cell …
and stimulated higher expansion … + T cells concomitantly limiting the peripheral CD8 + T cell …
1369 Engineering approaches to exploit MHC-II presentation on lung cancer cells
11 天前 - … that CD4 + T cell recognition of MHC-II antigens plays a major role in immunotherapy
responses, including tumor infiltrating lymphocyte (TIL) therapy and cancer vaccines. Most …
responses, including tumor infiltrating lymphocyte (TIL) therapy and cancer vaccines. Most …
[HTML][HTML] 920 ROSE12, a novel anti-CTLA-4 switch antibody with FcγR affinity-enhanced Fc, evokes tumor-selective anti-tumor immune response, activated by …
…, Y Matsuda, T Tsunenari, M Honda, T Nemoto… - 2024 - jitc.bmj.com
11 天前 - … Regulatory T cells (Tregs) are considered potential targets in cancer immunotherapy,
as tumor-infiltrating … One promising way to evoke effective anti-tumor immunity in cancer …
as tumor-infiltrating … One promising way to evoke effective anti-tumor immunity in cancer …
917 Targeting the TGF-β-SKI axis mitigates tumor immune exclusion
AB Chen, H Li, Y Wan - 2024 - jitc.bmj.com
11 天前 - … + T cells in MC38 tumors, but not in B16 tumors. Among the tumor-infiltrating
lymphocytes (TILs) in ERCre mice, there was decreased PD-1/TIM3 expression for CD4 + cells. …
lymphocytes (TILs) in ERCre mice, there was decreased PD-1/TIM3 expression for CD4 + cells. …
1353 Disrupting pro-tumorigenic fibroblast functions by targeting Pin1
M Chow, M O'Shea, L Ein, J Arnold, S Alnemy, E Dube… - 2024 - jitc.bmj.com
11 天前 - … form a formidable barrier to conventional immunotherapies by various means,
including … signaling with cancer cells, and interactions with tumor-infiltrating lymphocytes. The …
including … signaling with cancer cells, and interactions with tumor-infiltrating lymphocytes. The …
525 Adenosine uptake through equilibrative nucleoside transporter-1 suppresses antitumor immunity by pyrimidine starvation
D Allard, J Cormery, S Bricha, C Fuselier, L Giraud… - 2024 - jitc.bmj.com
11 天前 - … with decreased tumor-infiltrating T regulatory cells and CD206 … T cells upregulated
ENT1 following activation and … that can be targeted to enhance antitumor T cell responses. …
ENT1 following activation and … that can be targeted to enhance antitumor T cell responses. …
1356 Antigen-presenting CAFs are required for immunotherapy-mediated tumor response in PDAC tumors
S Maru, M Wetzel, J Mitchell, N Gross, L Andaloori… - 2024 - jitc.bmj.com
11 天前 - … T cells than apCAFs from rKPC tumors. apCAFs and CD11c + dendritic cells robustly
activate naïve OT-II CD4 + T cells… cultured with tumor infiltrating CD4 + T cells. Remarkably…
activate naïve OT-II CD4 + T cells… cultured with tumor infiltrating CD4 + T cells. Remarkably…
1310 Peripheral blood and tumor gene expression as biomarkers and potential predictors of clinical outcome with HST-1011, an oral CBL-B inhibitor
…, F Wang, Y Bi, K Carson, J Kuai, G Harriman, T Reilly… - 2024 - jitc.bmj.com
11 天前 - … While limited by sample size, transcriptional changes in the TME indicative of
tumor infiltrating lymphocytes were elevated in on-treatment biopsies for some patients, with …
tumor infiltrating lymphocytes were elevated in on-treatment biopsies for some patients, with …
896 VCAM-1+ tumor associated macrophages form perivascular tumor niches and drive resistance to anti-CTLA-4 therapy
11 天前 - … of tumor-infiltrating immune cells … T cells at later timepoints in B16F10 tumors.
Conclusions Collectively, our findings uncover VCAM-1 + TAMs as negative regulators of T cells …
Conclusions Collectively, our findings uncover VCAM-1 + TAMs as negative regulators of T cells …